Epilepsy Trial, Recruiting NCT02890641 Sponsor: Fondation Ophtalmologique Adolphe de Rothschild Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT02890641
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children who have epilepsy that has not been controlled by medication, where the seizures start in one specific area of the brain, and where the cause is one of the following conditions: Focal Cortical Dysplasia, Hemimegalencephaly, Tuberous Sclerosis, MOGHE, Hypothalamic Hamartomas, Sturge-Weber syndrome, Rasmussen encephalitis, or brain gliomas
  • Parents or guardians who have given written consent both for their child to take part and for themselves to take part
  • Families who are covered by French social security or an equivalent recognised insurance scheme in France

Who may not be able to join:

  • Families or children who do not wish to take part in the study
  • Children for whom anaesthesia, MRI scanning, or surgery is medically not suitable
  • Children or families who do not have medical insurance coverage

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mathilde CHIPAUX, MD, PhD, Fondation A de Rothschild

Phone: +33 1 48 03 64 54

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Registry
ClinicalTrials.gov
Start date
17 December 2015
Est. completion
1 December 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

qualitative genetic analysis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov